Precigen (PGEN) EBITDA Margin Growth (3y) (2015 - 2025)
Precigen (PGEN) EBITDA Margin Growth (3y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -42,530.00 |
| Sep 30, 2025 | -360,834.00 |
| Jun 30, 2025 | -323,707.00 |
| Mar 31, 2025 | -128,318.00 |
| Dec 31, 2024 | -98,984.00 |
| Sep 30, 2024 | -212.56 Mn |
| Jun 30, 2024 | -779,831.00 |
| Mar 31, 2024 | -221,986.00 |
| Dec 31, 2023 | -260,507.00 |
| Sep 30, 2023 | -209.36 Mn |
| Jun 30, 2023 | -115,636.00 |
| Dec 31, 2022 | 55,407.00 |
| Sep 30, 2022 | 13,757.00 |
| Jun 30, 2022 | -76,452.00 |
| Mar 31, 2022 | -21,651.00 |
| Dec 31, 2021 | 86,795.00 |
| Sep 30, 2021 | -45,189.00 |
| Jun 30, 2021 | -60,580.00 |
| Mar 31, 2021 | 4,151.00 |
| Dec 31, 2020 | -14,751.00 |